Evaluation of the efficacy of budesonide+terbutaline in the treatment of acute exacerbation of chronic obstructive pulmonary disease
布地奈德+特布他林治疗急性加重期慢性阻塞性肺疾病的效果评估

摘要

目的 考察联合吸入布地奈德和特布他林对急性发作期慢阻肺病人的临床改善情况。方法 将2024年5月至2025年6月就诊的74例急性加重期慢阻肺患者作为前瞻性分析对象，通过数字表随机抽样均分2组，对照组（37例）进行常规治疗，观察组（37例）则进行布地奈德+特布他林治疗。对患者整体治疗效果以及症状改善用时统计。结果 整体治疗有效率方面，观察组高于对照组（P<0.05）。与对照组相比，观察组各症状的改善耗时更少（P<0.05）。结论 对于慢性阻塞性肺疾病急性加重期病例，联合使用布地奈德和特布他林进行治疗，能够促使患者的临床症状在较短时间内得到有效改善，提升临床治疗有效率，起到帮助患者进行恢复的作用。

Abstract

Objective Investigating the clinical improvement of combined inhalation of budesonide and terbutaline in patients with acute exacerbation of chronic obstructive pulmonary disease.
Methods A prospective analysis was conducted on 74 patients with acute exacerbation of chronic obstructive pulmonary disease who were treated from May 2024 to June 2025. The patients were randomly divided into two groups using a digital table. The control group (37 cases) received conventional treatment, while the observation group (37 cases) received treatment with budesonide and terbutaline. Statistics on the overall treatment effect and symptom improvement time of patients.
Results In terms of overall treatment efficacy, the observation group was higher than the control group, (P<0.05). Compared with the control group, the observation group took less time to improve each symptom (P<0.05).
Conclusion   For cases of acute exacerbation of chronic obstructive pulmonary disease, the combined use of budesonide and terbutaline can effectively improve the clinical symptoms of patients in a short period of time, enhance the effectiveness of clinical treatment, and help patients recover.